Exagen Inc. (XGN)
NASDAQ: XGN · Real-Time Price · USD
3.060
+0.050 (1.66%)
At close: Apr 2, 2026, 4:00 PM EDT
3.100
+0.040 (1.31%)
After-hours: Apr 2, 2026, 7:53 PM EDT
Exagen Market Cap
Exagen has a market cap or net worth of $73.6 million as of April 2, 2026. Its market cap has increased by 9.66% in one year.
Market Cap
73.60M
Enterprise Value
69.05M
1-Year Change
9.66%
Ranking
Category
Stock Price
$3.06
Market Cap Chart
Since September 19, 2019, Exagen's market cap has increased from $63.11M to $73.60M, an increase of 16.63%. That is a compound annual growth rate of 2.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 73.60M | -46.58% |
| Dec 31, 2025 | 137.79M | 90.55% |
| Dec 31, 2024 | 72.31M | 113.18% |
| Dec 29, 2023 | 33.92M | -13.39% |
| Dec 30, 2022 | 39.17M | -79.17% |
| Dec 31, 2021 | 187.99M | 12.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fulgent Genetics | 485.17M |
| Myriad Genetics | 444.16M |
| Prenetics Global | 331.18M |
| Burning Rock Biotech | 174.42M |
| Biodesix | 148.57M |
| FONAR | 121.87M |
| Insight Molecular Diagnostics | 120.95M |
| MDxHealth | 110.95M |